Major treatment considerations for attention-deficit hyperactivity disorder.
Safer
D J
DJ
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D003913:Dextroamphetamine / Q000627:therapeutic use*; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*
D000929:Antidepressive Agents, Tricyclic; D008774:Methylphenidate; D003913:Dextroamphetamine